Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Salestools Logo

Salestools

L'agent IA #1 pour les équipes de vente et Go-to-Market. Vendez plus, plus vite, avec moins d'effort.

Produit

  • Agents de vente IA
  • Données d'intention
  • Données technologiques
  • Suivi des visiteurs
  • Copilote
  • Vente sociale

Solutions

  • Service client
  • E-commerce
  • SaaS
  • Entreprise
  • Petite entreprise

Ressources

  • Le rapport
  • Documentation
  • Référence API
  • Centre d'aide
  • Blog
  • Études de cas
  • Webinaires

Entreprise

  • À propos
  • Carrières
  • Presse
  • Contact
  • Partenaires

Nos bureaux

  • New York, HQ
  • Bucarest, Laboratoire de recherche IA
  • Zug, Suisse

© 2025 Salestools. Tous droits réservés.

Conditions relatives aux données et sécuritéPolitique de confidentialitéConditions de service
Tous les systèmes opérationnels
Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Back to The Report
Fundraising

OctoML

OctoML Raises $132M in Series C

2019
Founded
150+
Employees
2100 Elliott Avenue, Seattle, WA 98121
Updated June 22, 2024
2 min read

Quick Facts

OctoML Raises $132M in Series C


OctoML has successfully raised $132M in a Series C at a $700M valuation led by Addition, Tiger Global, Madrona Venture Group, Amplify Partners, Venrock.


Company Overview


OctoML is a AI/ML company headquartered in 2100 Elliott Avenue, Seattle, WA 98121, founded in 2019 with 150+ employees.


ML acceleration platform


Fundraising Details


  • Amount Raised: $132M
  • Round Type: Series C
  • Valuation: $700M
  • Date: 2024-06-22
  • Investors: Addition, Tiger Global, Madrona Venture Group, Amplify Partners, Venrock

About OctoML


ML acceleration platform The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 2100 Elliott Avenue, Seattle, WA 98121
  • Founded: 2019
  • Team Size: 150+
  • Industry: AI/ML

What This Means


This funding round demonstrates strong investor confidence in OctoML's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. OctoML's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $700M valuation marks an important milestone for OctoML, positioning the company among notable players in the AI/ML industry.


Looking Ahead


With this new capital, OctoML is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-06-22. For more information about OctoML, visit their headquarters at 2100 Elliott Avenue, Seattle, WA 98121.

Topics

Fundraising(2912)AI/ML(481)Series C(291)OctoML

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million